EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Chemical and Molecular Strategies in Restoring Autophagic Flux in TDP-43 Proteinopathy

Angelo Jamerlan iD, John Hulme iD

Molecules · 10.03.2026 · 31 (6) · 924

DOI: 10.3390/molecules31060924 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 10.03.2026. Verfasst von Angelo Jamerlan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bionanotechnology, Bionano Research Institute, Gachon University, Seongnam 13120, Gyeonggi-do, Republic of Korea. Hauptthemen laut MEDLINE: Autophagy, TDP-43 Proteinopathies, DNA-Binding Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Institute of Marine Science and Technology Promotion, National Research Foundation of Korea, Korea Institute of Marine Science & Technology Promotion.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cytoplasmic accumulation of TDP-43 aggregates remains a persistent pathological hallmark of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and limbic-predominant age-related TDP-43 encephalopathy (LATE). The cell’s natural clearance mechanisms, the Ubiquitin-Proteasome System (UPS) and the autophagy-lysosome pathway (ALP), are hypothesized to fail, at least in part, due to the sequestration of key components of these pathways by pathological TDP-43 species, thereby impairing autophagosome-lysosome fusion and lysosomal competence. Classical autophagic activators (e.g., rapamycin) can initiate upstream steps in the pathway but cannot address downstream flux bottlenecks, limiting their ability to restore effective TDP-43 clearance. This review revisits classical strategies and discusses newer approaches to modulate TDP-43 clearance, including transcription factor EB (TFEB) activators, proteolysis-targeting chimeras (PROTACs), and antisense oligonucleotides (ASOs). We propose that adopting multi-targeting strategies and developing better biomarkers are vital for clinical success.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyTDP-43 ProteinopathiesDNA-Binding ProteinsHumansAnimalsLysosomesProteolysis Targeting ChimeraBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsOligonucleotides, Antisense

Stichwörter der Autor:innen

PROTACsTDP-43 proteinopathyamyotrophic lateral sclerosisautophagic fluxautophagy-lysosome pathwayfrontotemporal dementianeurodegenerationproteostasis

Substanzen

DNA-Binding ProteinsProteolysis Targeting ChimeraBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsTARDBP protein, humanOligonucleotides, Antisense

Autor:innen und Institutionen

  • Department of Bionanotechnology, Bionano Research Institute, Gachon University, Seongnam 13120, Gyeonggi-do, Republic of Korea.

ORCID-Profile: Angelo Jamerlan, John Hulme

Förderung

  • Korea Institute of Marine Science and Technology Promotion
  • National Research Foundation of Korea
  • Korea Institute of Marine Science & Technology Promotion
  • Ministry of Oceans and Fisheries
  • Basic Science Research Program through the National Research Foundation of Korea
  • Ministry of Education

Zitieren

APA

Jamerlan, A., & Hulme, J. (2026). Chemical and Molecular Strategies in Restoring Autophagic Flux in TDP-43 Proteinopathy. Molecules, 31(6), 924. https://doi.org/10.3390/molecules31060924

Vancouver

Jamerlan A, Hulme J. Chemical and Molecular Strategies in Restoring Autophagic Flux in TDP-43 Proteinopathy. Molecules. 2026;31(6):924. doi:10.3390/molecules31060924

BibTeX
@article{Jamerlan2026,
  author = {Jamerlan, Angelo and Hulme, John},
  title = {Chemical and Molecular Strategies in Restoring Autophagic Flux in TDP-43 Proteinopathy},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {6},
  pages = {924},
  doi = {10.3390/molecules31060924}
}
Kostenlos starten →